Keeping You Updated
Here is a selection of recent PharmaVentures press releases...
Major New Report Highlights Growing Importance of IP Strategies and Competition Law in the Pharmaceuticals Industry
PharmaVentures announced today the publication of the report ‘Competition Law and Intellectual Property Strategy in the Pharmaceuticals Sector’, written by Richard Eccles and Gerry Kamstra, partners in the leading international law firm, Bird & Bird
PharmaVentures acted as advisor for sale of PhotoBioChem, N.V. patent assets to SpectraCure, AB
PharmaVentures announced today that it had acted as an advisor and broker to the PhotoBioChem, N.V. Holland for the sale of its patent assets to SpectraCure AB, Sweden.
PharmaVentures acted as advisor for sale of Dowpharma Small Molecules business to Dr Reddy’s Laboratories
PharmaVentures announced today that it acted as advisor to the Dow Chemical Company (NYSE:DOW) for the sale of Dowpharma Small Molecules business to Dr. Reddy’s Laboratories (NYSE:RDY).
Anne Vindenes Allen Joins PharmaVentures Ltd to Head Publishing Operations
PharmaVentures announced today the appointment of Anne Vindenes Allen MSc as Chief Operating Officer of PharmaDeals, the new publishing division of PharmaVentures Ltd. Fintan Walton, PhD, PharmaVentures’ Chief Executive Officer says, “We have a large and loyal following for the PharmaDeals database within the pharmaceutical and biotechnology business sector, and have plans to roll out some truly exciting developments in the coming months. We are delighted Anne will join us to steer these developments. Her experience of managing complex web technology implementations combined with her publishing expertise will be invaluable in helping us position our products to better serve our discerning customers.”